Literature DB >> 9420492

Underreporting of mortality from RhD haemolytic disease in Scotland and its implications: retrospective review.

C R Whitfield1, A Raafat, S J Urbaniak.   

Abstract

Entities:  

Mesh：

Year:  1997        PMID： 9420492      PMCID： PMC2127934          DOI： 10.1136/bmj.315.7121.1504

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  Preventing RhD haemolytic disease of the newborn. Revised guidelines advocate two doses of anti-D immunoglobulin for antenatal prophylaxis.

Authors:  D Lee
Journal:  BMJ       Date:  1998-05-23

2.  Human platelet antigen (HPA)-1a peptides do not reliably suppress anti-HPA-1a responses using a humanized severe combined immunodeficiency (SCID) mouse model.

Authors:  D J Jackson; J L Eastlake; B M Kumpel
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

3.  Treatment requirements of infants with rhesus isoimmunisation within a geographically defined area.

Authors:  A Greenough; G Hartnoll; H Hambley; J Richards
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-11       Impact factor: 5.747

4.  Routine antenatal anti-D prophylaxis in women who are Rh(D) negative: meta-analyses adjusted for differences in study design and quality.

Authors:  Rebecca M Turner; Myfanwy Lloyd-Jones; Dilly O C Anumba; Gordon C S Smith; David J Spiegelhalter; Hazel Squires; John W Stevens; Michael J Sweeting; Stanislaw J Urbaniak; Robert Webster; Simon G Thompson
Journal:  PLoS One       Date:  2012-02-03       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.